| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(81)91971-1 |
| P698 | PubMed publication ID | 6110913 |
| P2093 | author name string | W Howson | |
| C R Stiller | |||
| P A Keown | |||
| N R Sinclair | |||
| W J Wall | |||
| G Carruthers | |||
| R A Ulan | |||
| P2860 | cites work | Prolonged survival of pig orthotopic heart grafts treated with cyclosporin A. | Q39492216 |
| Induction of specific tolerance in rabbits by kidney allografting and short periods of cyclosporin-A treatment | Q39555196 | ||
| Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers | Q39574059 | ||
| Anti-Donor Immune Responses in Prediction of Transplant Rejection | Q39763612 | ||
| Cyclosporin A, a powerful immunosuppressant in vivo and in vitro in the dog, fails to induce tolerance | Q70523571 | ||
| Selective effects of cyclosporin A on colony-forming lymphoid and myeloid cells in man | Q80983586 | ||
| P433 | issue | 8222 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cyclosporine | Q367700 |
| P1104 | number of pages | 4 | |
| P304 | page(s) | 686-689 | |
| P577 | publication date | 1981-03-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Immunological and pharmacological monitoring in the clinical use of cyclosporin A | |
| P478 | volume | 1 |
| Q41786958 | A prospective study of cyclosporine concentration in relation to its therapeutic effect and toxicity after renal transplantation |
| Q41809979 | Chronic administration of cyclosporin A induces a decrease in hepatic excretory function in man |
| Q39729593 | Clinical pharmacokinetics of cyclosporin |
| Q36447399 | Concentrations of ciclosporin in allogeneic bone marrow recipients. Comparison of assay methods |
| Q40131054 | Cyclosporin A - Usefulness, Risks and Mechanism of Action |
| Q72500702 | Cyclosporin A in oliguric renal transplant recipients |
| Q34548058 | Cyclosporin A nephrotoxicity related to changes in haemoglobin concentration |
| Q40615260 | Cyclosporin A: a new advance in transplantation. |
| Q34278064 | Cyclosporin A: a powerful immunosuppressant |
| Q70436213 | Cyclosporin A: correlation between HPLC and RIA serum levels |
| Q42614071 | Cyclosporin A: tissue levels following topical and systemic administration to rabbits |
| Q70302607 | Cyclosporin a used alone or in combination with low-dose steroids in cadaveric renal transplantation |
| Q70302612 | Cyclosporin a: Pharmacologic activity on the immune system and effects in clinical organ transplantation |
| Q40918376 | Cyclosporin clinical pharmacokinetics |
| Q72556296 | Cyclosporin-A deposits in renal allografts |
| Q73114890 | Cyclosporine monitoring with levels 6 hours after the morning dose in patients with noninfectious uveitis |
| Q40176613 | Cyclosporine: a powerful addition to the immunosuppressive armamentarium |
| Q39733566 | Cyclosporine: a review of drug monitoring problems and presentation of a simple, accurate liquid chromatographic procedure that solves these problems |
| Q71773266 | Cyclosporine: action, pharmacokinetics, and effect in the BB rat model |
| Q40200051 | Cyclosporine: immunology, toxicity and pharmacology in experimental animals |
| Q44590795 | Cytokines Regulate the Pattern of Rejection and Susceptibility to Cyclosporine Therapy in Different Mouse Recipient Strains After Cardiac Allografting |
| Q44537877 | Disappearance and reappearance of islet cell cytoplasmic antibodies in cyclosporin-treated insulin-dependent diabetics |
| Q42400641 | Diurnal variation in cyclosporine kinetics |
| Q37052552 | Effects of cyclosporine in experimental cryptococcal meningitis. |
| Q41874828 | Evaluation of cyclosporin-phenytoin interaction with observations on cyclosporin metabolites |
| Q34275840 | Evolution of liver transplantation |
| Q34728490 | Experience of a Canadian multi-organ transplant service |
| Q34786118 | How pharmacokinetic and pharmacodynamic drug monitoring can improve outcome in solid organ transplant recipients |
| Q44101173 | Immunopharmacodynamic profiles in children with renal allografts receiving cyclosporine therapy |
| Q34396340 | Importance of endogenous prostaglandins for the toxicity of cyclosporin A to rat endocrine and exocrine pancreas? |
| Q68124503 | Lymphocyte subpopulation monitoring in cyclosporine-treated patients following heart transplantation |
| Q39516763 | Management of heart transplant recipients: guidelines for the obstetrician-gynecologist |
| Q72500712 | Nephrotoxicity of cyclosporin A |
| Q70191600 | Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: glomerular thromboses and tubular injury |
| Q72494980 | Nephrotoxicity of cyclosporin A in bone marrow transplant recipients |
| Q72477823 | Nephrotoxicity of cyclosporin A in bone-marrow transplantation |
| Q37781449 | Novel Strategies for Immune Monitoring in Kidney Transplant Recipients |
| Q70313028 | Oral administration of cyclosporin A for recipients of allogeneic marrow transplants: implications of clinical gut dysfunction |
| Q69531256 | Organization of a clinical transplant unit: general guidelines |
| Q72494972 | Paracetamol interference with glucose analysis |
| Q35572368 | Pharmacodynamic monitoring of cyclosporin |
| Q37909318 | Pharmacokinetic drug interactions with phenytoin (Part II). |
| Q44776777 | Post-transplant acute renal failure in cadaver renal recipients treated with cyclosporine |
| Q72477811 | Primary biliary cirrhosis: experience in a non-referral centre |
| Q41107053 | Renal and segmental pancreatic grafting with draining of exocrine secretion and initial continuous intravenous cyclosporin A in a patient with insulin-dependent diabetes and renal failure |
| Q72477830 | Serum levels of cyclosporin A and nephrotoxicity in bone marrow transplant patients |
| Q72471524 | The effect of long-term cyclosporin A on renal function |
| Q77369533 | The evolution of therapeutic drug monitoring of cyclosporine |
| Q38113083 | The impact of APOL1, CAV1, and ABCB1 gene variants on outcomes in kidney transplantation: donor and recipient effects |
| Q35711332 | Therapeutic drug monitoring of cyclosporine: 20 years of progress |
| Q37018612 | Therapeutic monitoring of cyclosporin ? an update |
| Q42592301 | Tolazoline and acute renal failure in the newborn |
| Q37311411 | Variable convalescence and therapy after cadaveric renal transplantation under cyclosporin A and steroids |
Search more.